Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Irina K. Asherova"'
Autor:
Alexander A. Baranov, Leyla S. Namazova-Baranova, Sergey I. Kutsev, Sergey N. Avdeev, Elena V. Polevichenko, Andrey S. Belevskiy, Elena I. Kondratyeva, Olga I. Simonova, Nataliya Yu. Kashirskaya, Victoria D. Sherman, Anna Yu. Voronkova, Evgeniya L. Amelina, Tatyana E. Gembitskaya, Stanislav A. Krasovskiy, Alexey G. Chermenskiy, Tatyana A. Stepanenko, Liliia R. Selimzyanova, Elena A. Vishneva, Yulia V. Gorinova, Elena A. Roslavtseva, Irina K. Asherova, Natalya A. Ilyenkova, Sergey K. Zyryanov, Niso D. Odinayeva, Tatyana Yu. Maksimycheva, Alexander V. Orlov, Sergey Yu. Semykin, Marina Yu. Chernukha, Igor A. Shaginyan, Lusine R. Avetisyan, Galina L. Shumkova, Natalya A. Krylova, Ivan A. Dronov, Maria N. Kostyleva, Ludmila A. Zhelenina, Nikolay N. Klimko, Yuliya V. Borzova, Natalya V. Vasilyeva, Tatyana S. Bogomolova, Anna A. Speranskaya, Irina A. Baranova, Evgeny G. Furman, Vera V. Shadrina, Nikolay F. Shchapov, Nika V. Petrova, Ivan V. Pashkov, Olga M. Tsirulnikova, Dmitriy P. Polyakov, Valeriy M. Svistushkin, Eduard V. Sin'kov, Vyacheslav B. Chernykh, Svetlana A. Repina, Dmitriy A. Blagovidov, Mikhail P. Kostinov, Olga V. Kondratenko, Artem V. Lyamin, Svetlana V. Polikarpova, Alexander V. Polyakov, Tagui A. Adyan, Dmitry V. Goldshtein, Tatiana B. Bukharova, Anna S. Efremova, Elena S. Ovsyankina, Ludmila V. Panova, Irina V. Cherkashina
Publikováno v:
Педиатрическая фармакология, Vol 19, Iss 2, Pp 153-195 (2022)
The problem of timely diagnosis and proper management of patients with cystic fibrosis is crucial not only in our country, but throughout the world. Experts of the Union of Pediatricians of Russia have considered various issues of etiology, pathogene
Externí odkaz:
https://doaj.org/article/143f4fcbf4674dee93deee9bc716f441
Autor:
Elena L Amelina, Stanislav A Krasovsky, Nina E Akhtyamova-Givirovskaya, Nataliya Yu Kashirskaya, Diana I Abdulganieva, Irina K Asherova, Ilya E Zilber, Liliya S Kozyreva, Lubov M Kudelya, Natalya D Ponomareva, Nataliya P Revel-Muroz, Elena M Reutskaya, Tatiana A Stepanenko, Gulnara N Seitova, Olga P Ukhanova, Olga V Magnitskaya, Dmitry A Kudlay, Oksana A Markova, Elena V Gapchenko
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0261410 (2021)
BackgroundPatients with cystic fibrosis (CF) need costly medical care and adequate therapy with expensive medicinal products. Tigerase® is the first biosimilar of dornase alfa, developed by the lead Russian biotechnology company GENERIUM. The aim of
Externí odkaz:
https://doaj.org/article/e8737b56062f40718a177ef1474c9033
Publikováno v:
Acta Paediatrica. 95:1513-1514